It is not totally clear why the LTR-containing MLV vector caused insertional oncogenesis in SCID-X1 but not ADA-SCID, but similar insertional oncogenesis in patients treated for chronic granulomatous disease and Wiskott–Aldrich syndrome suggests that ADA deficiency offers some intrinsic protection [55,56]. This evidence concerns the gene ADA and chronic granulomatous disease.